Skip to content
777 Sourcing.

Capability

chemoproteomics (Universal Purinome Capture Platform)

Suppliers
1
States & provinces
1
Countries
1

1 chemoproteomics (universal purinome capture platform) supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

EYDIS BIO, INC.

DURHAM, NC

EydisBio is a small biotech startup based in Durham, NC focused on the development of highly selective and potent novel small molecule kinase inhibitors. Its current TAK1 program is described as the first to develop a highly selective, orally bioavailable inhibitor of TAK1 for the treatment of inflammatory-mediated diseases such as RA, systemic sclerosis, chronic pain, viral-induced ARDS, and SLE. The company uses its Universal Purinome Capture Platform (UPCP) chemoproteomics platform to identify protein kinases of interest.

preclinical developmentpurine-based small molecule compound developmentsmall molecule discovery and development

Compiled from public sources

Related capabilities

Other processes offered by the shops that list chemoproteomics (Universal Purinome Capture Platform).

Browse all capabilities